Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Dose comparison trial of sustained-release fampridine in multiple sclerosis.
Reduced cerebrospinal fluid concentrations of oxysterols in response to natalizumab treatment of relapsing remitting multiple sclerosis.
Change in the clinical development program for laquinimod
The influence of patient demographics, disease characteristics and treatment on brain volume loss in Trial Assessing Injectable Interferon vs FTY720 Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS), a phase 3 study of fingolimod in multiple scl
A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial.
Glatiramer Acetate 40 mg/mL in Relapsing-Remitting Multiple Sclerosis: A Review.
The Relative Importance of Baseline Pain, Fatigue, Sleep and Physical Activity: Predicting Change in Depression in Adults with Multiple Sclerosis.
Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
Teva announces top-line results from GALA Phase III trial evaluating a new dosage for glatiramer acetate given three times weekly for relapsing-remitting multiple sclerosis
The two faces of neuromyelitis optica.
Gender identity disorders and multiple sclerosis risk: A national record-linkage study.
Pathway and network-based analysis of genome-wide association studies in multiple sclerosis.
Efficacy of remission-induction regimens for ANCA-associated vasculitis.
Dimethyl fumarate modulates antioxidant and lipid metabolism in oligodendrocytes.
Glatiramer acetate in the treatment of multiple sclerosis
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study.
Pharmacokinetics of CAMPATH-1H in BMT patients.
Emotional Change-Associated T Cell Mobilization at the Early Stage of a Mouse Model of Multiple Sclerosis.
Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system.
Synthetic Biologics Announces Issuance of U.S. Patent Adding Another Layer of Protection for the Use of Oral Estriol Candidate, Trimesta™, for Multiple Sclerosis
Effect of the Kv7-channel Opener Flupirtine on the Excitability of Human Peripheral Myelinated Axons in Vivo
Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome.
LC-MS/MS determination of FTY720 and FTY720-phosphate in murine intracellular compartments and human plasma.
The interplay between the intestinal microbiota and the brain.
Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants.

Pages